Clinical Science Support

Learn why advanced guidance at the bedside will significantly improve patient outcomes and reduce cost to the healthcare system

External Ventricular Drains

Common indications for external ventricular drains (EVDs) include hydrocephalus and/or traumatic brain injury
Little has changed with this common but lifesaving procedure for more than 100 years
Results of free-hand procedures can vary drastically, in the final catheter location, number of attempts, and overall procedural time
This can have a negative impact on patient outcomes and increase the cost of hospitalization

Hematoma Evacuation

According to the World Health Organization, 15 million people suffer from strokes worldwide each year. Of these, 5 million die and another 5 million are permanently disabled.
Approximately 8% to 15% of all strokes are hemorrhagic. Depending on severity, treatment includes intracranial pressure monitoring, introduction of rTPA or “clot buster” medications and, in some cases, clot aspiration.
Treating hemorrhagic stroke requires imaging not available in the ICU, meaning that critically ill patients moved to various locations in the hospital for imaging, and then ultimately the operating room – posing risks to these tenuous patients

**SOLOPASS® has not been cleared or approved for treatment of hematoma evacuation by the U.S. Food and Drug Administration for sale in the United States.

Clinical Science Support

Learn why advanced guidance at the bedside will significantly improve patient outcomes and reduce cost to the healthcare system

External Ventricular Drains

Common indications for external ventricular drains (EVDs) include hydrocephalus and/or traumatic brain injury

Little has changed with this common but lifesaving procedure for more than 100 years

Results of free-hand procedures can vary drastically, in the final catheter location, number of attempts, and overall procedural time

This can have a negative impact on patient outcomes and increase the cost of hospitalization

Hematoma Evacuation

According to the World Health Organization, 15 million people suffer from strokes worldwide each year. Of these, 5 million die and another 5 million are permanently disabled.

Approximately 8% to 15% of all strokes are hemorrhagic. Depending on severity, treatment includes intracranial pressure monitoring, introduction of rTPA or “clot buster” medications and, in some cases, clot aspiration.

Treating hemorrhagic stroke requires imaging not available in the ICU, meaning that critically ill patients moved to various locations in the hospital for imaging, and then ultimately the operating room – posing risks to these tenuous patients

Learn more about how we are enhancing the future of Neurosurgery.